Scientific validity of thiamazole’s in vitro kinetic from «Thyreoderm-TTS» innovative transdermal therapeutic system

  • V. Ye. Butska -
  • S. V. Ratushnyi -
  • T. O. Shiteeva -
  • O. I. Golembiovska -
Keywords: transdermal therapeutic system, thiamazole, biopharmaceutical research, Mercazolil-Zdorovye tablets

Abstract

In vitro investigation of thiamazole’s kinetic from innovative transdermal therapeutic system, which included 2% of active substance compared with Mercazolil-Zdorovye tablets, was conducted. Prolonged kinetic of active substance from transdermal therapeutic system were proved.

References

1. State Pharmacopoeia of Ukraine / State Enterprise "Scientific Expert Pharmacopoeia Center". - The first view. - Kharkov: RIREG, 2001. - P. 153-157.
2. Town Hall SV, Butska V.Ye., Timchenko O.G. The expediency of developing an innovative transdermal therapeutic system with Mercazolil for use in endocrinological practice // Eastern European Journal. public health. - 2012. - No. 1 (17) - P. 233.
3. Ratushny SV, Butskaya V.E. Development and research of an innovative drug with Mercazolil in the form of a transdermal therapeutic system // Development, research and marketing of new pharmaceutical products: Sat. scientific works of PGFA. - Pyatigorsk, 2012. - Issue 67. - P. 191-192.
4. Shiteva T.O. Development of the composition and standardization of production of transdermal therapeutic system of anti-inflammatory action "Dikolder": Dis. ... Candidate farm Sciences: 15.00.01. - Kh., 2004. - P. 52-54.
5. Arora A., Kisak E., Karande P. et al. Multicomponent chemical enhancer formulations for transdermal drug delivery: More is not always better // J. Controlled Release. - 2010. - V. 144. - P. 175-180.
6. Gutschke E., Bracht S., Nagel S., Weitschies W. Adhesion testing of transdermal matrix patches with a probe tack test - In vitro and in vivo evaluation // Europ. J. Pharmac. and Biopharmac. - 2010. - V. 75. - P. 399-404.
7. Longsheng Hu, Sergio M.C. Silva, Bassam B. Damaj et al. Transdermal and transbuccal drug delivery systems: Enhancement using iontophoretic and chemical approaches // International J. Pharmac. - 2011. - Vol. 421. - P. 53-62.
8. Piyush Jain, Ajay K. Wave. Inhibition of crystallization in drug-in-adhesive-type transdermal patches // Ibid. - 2010. - V. 394. - P. 68-74.
9. Qiuxi Fan, Kamalesh K. Sirkar, Bozena Michniak. Iontophoretic transdermal drug delivery system using a conducting polymeric membrane // J. Membrane Science. - 2008. - P. 321. - P. 240-249.
10. Lvovich V. F., Matthews E., Riga A. T., Kaza L. AC electrokinetic platform for iontophoretic transdermal drug delivery // J. Controlled Release. - 2010. - V. 145. - P. 134-140.
Published
2019-03-18
How to Cite
Butska, V. Y., Ratushnyi, S. V., Shiteeva, T. O., & Golembiovska, O. I. (2019). Scientific validity of thiamazole’s in vitro kinetic from «Thyreoderm-TTS» innovative transdermal therapeutic system. Farmatsevtychnyi Zhurnal, (4), 57-61. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/498
Section
Pharmaceutical technology

Most read articles by the same author(s)